2026
article
OpenAlex
María González‐Esguevillas, Aaron F. Baldwin, Pablo J. Cabrera, Yanfei Guan et autres
Abstract Ibuzatrelvir is an orally bioavailable, next-generation clinical candidate developed for the treatment of COVID-19 infections. It was identified during the pandemic, prior to the approval of PAXLOVID, and displays a more favorable pharmacokinetic profile than nirmatrelvir. Consequently, the initial development of …
us
(code pays fourni par la source)
Accès ouvert
2006
article
OpenAlex
Michael P. DeNinno, Hiroko Masamune, Lois K. Chenard, Kenneth J. DiRico et autres
us
(code pays fourni par la source)
Accès ouvert
2002
article
OpenAlex
Michael P. DeNinno, Hiroko Masamune, Lois K. Chenard, Kenneth J. DiRico et autres
Selective adenosine A(3) agonists have potential utility for the prevention of perioperative myocardial ischemic injury. Herein, we report on the discovery and synthesis of compound 7. This amino nucleoside agonist possesses unprecedented levels of selectivity for the human adenosine A(3) receptor.
us
(code pays fourni par la source)
1995
article
OpenAlex
Hiroko Masamune, John B. Cheng, Kelvin Cooper, James F. Eggier et autres
us
(code pays fourni par la source)
1995
article
OpenAlex
Hiroko Masamune, James F. Eggler, Anthony Marfat, Lawrence S. Melvin et autres
us
(code pays fourni par la source)
1995
article
OpenAlex
E. G. ANDREWS, G.W. Antognoli, R Breslow, Michael P. Carta et autres
us
(code pays fourni par la source)
1995
article
OpenAlex
Hiroko Masamune, R Breslow, John B. Cheng, Maryrose J. Conklyn et autres
us
(code pays fourni par la source)